Tenon Medical Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
2analysts covering
FY Revenue (est.)
$6.6Mnext fiscal year
FY EPS (est.)
-$0.85next fiscal year
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Growth Quarterly9,000.0%Target: 63% full-year growth
Gross Margin Quarterly6,850.0%Target: High 60s to low 70s
Cash and Cash Equivalents Quarterly4.6MTarget: Sufficient working capital to resolve going concern
Watch Items
- Nasdaq Minimum Bid Price ComplianceTrigger: Closing bid price below $1.00 for 30 consecutive business daysAction: Regain compliance by maintaining a minimum closing bid price of $1.00 for at least 10 consecutive business days before August 24, 2026, or execute a reverse stock split (authorized range of 1:2 to 1:35).
- Nasdaq Minimum Stockholders' Equity RequirementTrigger: Stockholders' equity below $2,500,000 (reported at $1,895,000 as of March 31, 2026)Action: Submit a compliance plan to Nasdaq by July 6, 2026, outlining strategies to increase equity (e.g., debt conversion, asset restructuring, or additional equity financing).
- Going Concern StatusTrigger: Substantial doubt about the company's ability to continue as a going concernAction: Secure additional equity or debt financing, manage cash burn, and accelerate commercial adoption of the Catamaran and SImmetry+ platforms to achieve self-sustaining cash flows.
Research as of 20 Jun 2026